Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes.
Guillermo Garcia ManeroMaria Diez CampeloEdo VellengaMeagan A JacobyBrayan MerchanDimitri BreemsAgostino CortelezziVadim DoroninValle GomezMarielle BeckersMatteo Giovanni Della PortaHelen VarsosLiang XiuNikki DeAngelisIvo NnaneEsther RoseKoen van EygenPublished in: American journal of hematology (2021)